These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34061521)

  • 21. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.
    Molgó J; Aráoz R; Benoit E; Iorga BI
    Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors.
    Alijevic O; McHugh D; Rufener L; Mazurov A; Hoeng J; Peitsch M
    Phytochemistry; 2020 Feb; 170():112187. PubMed ID: 31865001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors.
    Barker D; Lin DH; Carland JE; Chu CP; Chebib M; Brimble MA; Savage GP; McLeod MD
    Bioorg Med Chem; 2005 Jul; 13(14):4565-75. PubMed ID: 15922601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
    Nai Q; McIntosh JM; Margiotta JF
    Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptors.
    Faundez-Parraguez M; Farias-Rabelo N; Gonzalez-Gutierrez JP; Etcheverry-Berrios A; Alzate-Morales J; Adasme-Carreño F; Varas R; Bermudez I; Iturriaga-Vasquez P
    Bioorg Med Chem; 2013 May; 21(10):2687-94. PubMed ID: 23561269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenylated indole alkaloids from Flustra foliacea with subtype specific binding on NAChRs.
    Peters L; Wright AD; Kehraus S; Gündisch D; Tilotta MC; König GM
    Planta Med; 2004 Oct; 70(10):883-6. PubMed ID: 15490312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
    Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
    PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L; McIntosh JM
    Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.
    Xing H; Keshwah S; Rouchaud A; Kem WR
    Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32053997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice.
    Davis JA; Gould TJ
    Psychopharmacology (Berl); 2007 Feb; 190(3):343-52. PubMed ID: 17136517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
    Peng W; Ding F
    Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
    Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
    Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAIL-enhancing activity of Erythrinan alkaloids from Erythrina velutina.
    Ozawa M; Etoh T; Hayashi M; Komiyama K; Kishida A; Ohsaki A
    Bioorg Med Chem Lett; 2009 Jan; 19(1):234-6. PubMed ID: 19026536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imidacloprid acts as an antagonist on insect nicotinic acetylcholine receptor containing the Y151M mutation.
    Zhang Y; Liu S; Gu J; Song F; Yao X; Liu Z
    Neurosci Lett; 2008 Dec; 446(2-3):97-100. PubMed ID: 18824080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.